Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,877.00p
   
  • Change Today:
    -78.00p
  • 52 Week High: 2,340.00p
  • 52 Week Low: 1,772.00p
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 599,607
  • Market Cap: £4,405.69m
  • RiskGrade: 125
  • Beta: 0.00

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.3% 0.0%
Div Cover 2.8 2.9
Op Mrgn 19.6% 22.7%
ROCE 24.3%  
Latest F'cast
P/E 10.8 12.2
PEG 24.1 1.9
Pr/Revenue 1.8 1.6
Pr/Book 2.4  
Latest F'cast
Revenue 8.8% -18.9%
PBT 61.9% 26.5%
EPS 0.4% 2.9%
DPS 11.1% -39.6%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 2,341.00 558.00 172.90¢ 18.8 1.3 +15% 50.00¢ 1.5%
31-Dec-21 2,553.00 544.00 194.80¢ 14.7 1.1 +13% 54.00¢ 1.9%
31-Dec-22 2,517.00 233.00 181.00¢ 11.1 n/a -7% 56.00¢ 2.8%
31-Dec-23 2,875.00 281.00 223.00¢ 10.3 0.4 +23% 72.00¢ 3.1%
31-Dec-24 3,127.00 455.00 224.00¢ 11.5 n/a 0% 80.00¢ 3.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 3,271.33 742.30 178.15p 10.5 3.6 +3% 62.30p 0.0%
31-Dec-26 3,402.39 795.15 192.85p 9.7 1.2 +8% 66.43p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Block listing Interim Review 01-Apr-2025 09:30 RNS
Annual Financial Report and Notice of AGM 19-Mar-2025 10:10 RNS
Director/PDMR Shareholding 04-Mar-2025 11:16 RNS

HIK ShareCast News

London close: Stocks rise as investors look to N... 26-Feb-2025 ShareCast
Shares in Hikma fall after results disappoint 26-Feb-2025 ShareCast
London close: Stocks finish lower as Ashtead ann... 10-Dec-2024 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 1,877.00p
Change Today -78.00p
% Change -3.99 %
52 Week High 2,340.00p
52 Week Low 1,772.00p
Volume 599,607
Shares Issued 234.72m
Market Cap £4,405.69m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.11% below the market average88.11% below the market average88.11% below the market average88.11% below the market average88.11% below the market average
8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average
Price Trend
60.30% above the market average60.30% above the market average60.30% above the market average60.30% above the market average60.30% above the market average
59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average
Income
15.41% below the market average15.41% below the market average15.41% below the market average15.41% below the market average15.41% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
21.76% above the market average21.76% above the market average21.76% above the market average21.76% above the market average21.76% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 04-Apr-2025

Time Volume / Share Price
17:13 5,969 @ 1,918.14p
16:49 1,575 @ 1,877.00p
16:35 683 @ 1,877.00p
16:35 658 @ 1,877.00p
16:35 242,300 @ 1,877.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page